Search

Fellowship recipient Dr. Francisco Sanchez-Vega will research factors that lead to negative colorectal cancer outcomes in Black communities.

… Thursday, April 13, 2023 Corning Incorporated and Memorial Sloan Kettering Cancer Center (MSK) announced today that Dr. Francisco Sanchez-Vega, PhD, has been awarded the Corning-MSK Health Equity Research Fellowship, a two-year grant that funds research into the broad disparities in cancer outcomes for

A phase 3 trial led by MSK showed that adding epcoritamab to traditional treatment for follicular lymphoma benefits patients. Epcoritamab received FDA approval based on the findings.

… Sunday, December 7, 2025 Retired New York City police officer Michael T. had grown used to getting bad news about the follicular lymphoma  that he had been living with for more than 20 years. “I have a relapse about every five years,” says Michael, who was a 9/11 first responder and worked at Ground

Memorial Sloan Kettering scientists, physicians, and administrators are developing and commercializing research discoveries to generate more-effective and affordable cancer treatments.

… Thursday, December 1, 2011 Summary Memorial Sloan Kettering scientists, physicians, and administrators are developing and commercializing research discoveries to generate more-effective and affordable cancer treatments. At Memorial Sloan Kettering, scientists, physicians, and administrators strive to

The common wisdom is that genes are preserved from generation to generation because they help the organism survive and reproduce. But MSK's Dr. Eric Lai’s team is showing — in fruit flies — that certain genes can threaten a species’ very survival by pursuing their narrow self-interests in passing along their own genetic material.

… Monday, August 28, 2023 Developmental biologist Eric Lai, PhD , and his lab at Memorial Sloan Kettering Cancer Center (MSK) have been studying hotbeds of biological conflict. Only instead of battles between outside invaders and internal defenders, they’ve uncovered an evolutionary battle of the sexes

To celebrate National Nurses Week (May 6 to May 12), Today Show anchor Hoda Kotb interviewed MSK Nurse Cassie DeMatteis about an extraordinary relationship with one of her littlest patients.

… Tuesday, May 10, 2022 NBC's Hoda Kotb hugs MSK Nurse Cassie DeMatteis. NBC's Hoda Kotb hugs MSK Nurse Cassie DeMatteis. MSK Nurse Cassie DeMatteis speaks to NBC's Hoda Kotb about her special relationship with a pediatric patient and his family. MSK Nurse Cassie DeMatteis speaks to NBC's Hoda Kotb about

Four MSK clinicians were accepted into a career development program aimed at increasing diverse participation in clinical trials.

… Tuesday, November 16, 2021 On October 25, 2022, the Bristol Myers Squibb Foundation announced the second cohort of this program, now known as The Robert A. Winn Diversity in Clinical Trials Award Program. Two MSK clinicians, Drs. Fiyinfolu Balogun and Joshua Budhu , are in this second cohort and will

An international phase 3 clinical trial has shown that adding a targeted therapy to a standard combination for stage 4 kidney cancer is more effective than giving the standard treatment alone, although the new combination has significant side effects.

… Wednesday, May 10, 2023 Michael Szczerbienski had always been blessed with good health, so the day he found blood in his urine , he was quite alarmed. His doctor sent him for a CT scan , which revealed a tumor on his left kidney. Michael, whose kidney cancer was already advanced, went to Memorial Sloan

The Memorial Sloan Kettering – Hackensack Meridian Health Partnership has formed an Immunology Research Collaboration to support innovative investigations into the power of the immune system to fight cancer.

… Tuesday, June 9, 2020 As part of the Memorial Sloan Kettering – Hackensack Meridian Health Partnership, the two organizations have formed an Immunology Research Collaboration. Through this joint initiative, researchers can apply for funding to support innovative investigations to explore the power of

An antibody that targets a prostate cell protein shows potential for designing safer, more effective prostate cancer therapies.

… Tuesday, April 24, 2018 Summary Current prostate cancer drugs often lose their effectiveness over time. A new approach involves using an antibody to deliver toxic radioactive particles selectively to prostate cancer cells. There are many effective prostate cancer drugs, but a major challenge is that

An interdisciplinary team from Memorial Sloan Kettering Cancer Center has shown how antibiotics can disrupt the normal, healthy balance of microorganisms in the gastrointestinal tract.

… Friday, April 1, 2011 Summary An interdisciplinary team from Memorial Sloan Kettering Cancer Center has shown how antibiotics can disrupt the normal, healthy balance of microorganisms in the gastrointestinal tract. An interdisciplinary team from Memorial Sloan Kettering Cancer Center has shown that antibiotics